NSABP Members' Area
Password Protected - Access
Limited to NSABP Participating
Institutions Only
NSABP Foundation, Inc.
General NSABP Information
Financial Conflicts of
Interest Policy
Contact the NSABP
Employment
Clinical Trials Information
Clinical Trials Overview
Protocol Chart
Never Say Lost
Treatment Trials Information
Protocol B-51
Protocol B-52
Protocol B-53/S1207
Protocol B-55/BIG 6-13
Prevention Trials Information
Protocol P-1 - BCPT
Protocol P-2 - STAR
To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu
Protocol C-01
A Clinical Trial to Evaluate Postoperative Immunotherapy and Postoperative Systemic Chemotherapy in the Management of Resectable Colon Cancer
Specific Aims
To determine if the disease-free survival and survival of patients who have had a "curative" resection of the colon is improved by the addition of (1) the three-drug regimen, 5-FU, MeCCNU and vincristine, or (2) postoperative BCG immunotherapy. This study was also designed to provide information relative to the pathology of colon cancer that will contribute to a greater understanding of the natural history of this cancer so that subsets of patients who are at higher risk of recurrence can be identified.
